tiprankstipranks
Trending News
More News >
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market

Compare AN2 Therapeutics, Inc. (ANTX) vs. Competitors

Compare
96 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
AN2 Therapeutics, Inc.
$1.14
$34.25M
-1.06
-5.51%
Dyadic International
$0.93
$32.21M
-3.68
-41.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
Iterum Therapeutics
$0.34
$17.01M
-0.45
-77.92%
2 Buy
0 Hold
0 Sell
Moderate Buy
Clene
$5.05
$60.19M
-1.49
3.27%
5 Buy
0 Hold
0 Sell
Strong Buy
Xilio Therapeutics
$0.64
$33.61M
-0.97
-43.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
CAMP4 Therapeutics Corporation
$5.78
$299.87M
-2.29
26.29%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANTX
AN2 Therapeutics, Inc.
1.20
-0.07
-5.51%
DYAI
Dyadic International
0.87
-0.63
-42.00%
ITRM
Iterum Therapeutics
0.34
-1.20
-77.92%
CLNN
Clene
5.05
0.26
5.43%
XLO
Xilio Therapeutics
0.64
-0.50
-43.86%
CAMP
CAMP4 Therapeutics Corporation
5.62
1.00
21.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts